Reaginic antibody in experimental allergic encephalomyelitis. II. Histamine and serotonin blockade.
D000311:Adrenal Glands / Q000503:physiopathology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001886:Bordetella pertussis / Q000276:immunology; D003533:Cyproheptadine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000276:immunology*; D006168:Guinea Pigs / Q000276:immunology; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects*; D007073:Immunoglobulin E / Q000032:analysis*; D008297:Male; D008784:Methysergide / Q000627:therapeutic use; D009161:Mycobacterium / Q000276:immunology; D004676:Myelin Basic Protein / Q000097:blood / Q000276:immunology*; D009929:Organ Size; D010323:Passive Cutaneous Anaphylaxis; D011935:Reagins / Q000032:analysis*; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D012867:Skin / Q000276:immunology*; D012882:Skin Tests; D013116:Spinal Cord / Q000276:immunology; D013312:Stress, Physiological / Q000503:physiopathology; D013950:Thymus Gland / Q000503:physiopathology
D006634:Histamine H1 Antagonists; D004676:Myelin Basic Protein; D011935:Reagins; D012702:Serotonin Antagonists; D003533:Cyproheptadine; D012701:Serotonin; D007073:Immunoglobulin E; D006632:Histamine; D008784:Methysergide